FOLH1 and posterior cortical atrophy: Much effort has been made to therapeutically target PCa-specific cell surface receptors such as prostate-specific membrane antigen (PSMA) [21,22,23,24], DNA damage and repair (DDR) pathways [25,26], and bone metastasis niches [27,28].